BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY

Dna Probe, Nucleic Acid Amplification, Chlamydia

BECTON, DICKINSON & CO.

The following data is part of a premarket notification filed by Becton, Dickinson & Co. with the FDA for Bd Probetec Chlamydia Trachomatis (ct) Qx Amplified Dna Assay.

Pre-market Notification Details

Device IDK090824
510k NumberK090824
Device Name:BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY
ClassificationDna Probe, Nucleic Acid Amplification, Chlamydia
Applicant BECTON, DICKINSON & CO. 7 LOVETON CIR. Sparks,  MD  21152
ContactSaba Modjarrad
CorrespondentSaba Modjarrad
BECTON, DICKINSON & CO. 7 LOVETON CIR. Sparks,  MD  21152
Product CodeMKZ  
CFR Regulation Number866.3120 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2009-03-26
Decision Date2009-06-02
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.